Key Findings: There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and
LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema
NIAID support opens gateway to new research into human immune responses to viruses, the development of autoimmune diseases, and more